Shanghai Junshi Biosciences Co., Ltd. announced that Dr. Shen Jingkang and Dr. Yang Yue as independent non-executive Directors. The composition of the committees of the fourth session of the Board of Directors is as follows: the audit committee of the Company (the "Audit Committee") comprises two independent non-executive Directors, namely Mr. Zhang Chun (chairman of the Audit Committee) and Dr. Shen Jingkang, and one non-executive Director, namely Mr. Tang Yi; the nomination committee of the Company (the " Nomination Committee ") comprises two independent non-executive Directors, namely Dr. Feng Xiaoyuan (chairman of the Nomination Committee) and Dr. Yang Yue, and one executive Director, namely Mr. Xiong Jun; the remuneration and appraisal committee of the Company (the " Remuneration and Appraisal Committee") comprises three independent non-executive Directors, namely Mr. Zhang Chun (chairman of the Remuneration and Appraisal Committee), Dr. Feng Xiaoyuan and Dr. Yang Yue, and two executive Directors, namely Mr. Xiong Jun and Dr. Zou Jianjun; and the strategic committee of the Company (the " Strategic Committee ") comprises three independent non-executive Directors, namely Mr. Zhang Chun, Dr. Meng Anming and Dr. Shen Jingkang, and two executive Directors, namely Mr. Xiong Jun (chairman of the Strategic Committee) and Dr. Zou Jianjun. Dr. Feng Hui ("Dr. Feng") has not stood for re-election as a non-executive Director and will retire from his position with effect from the date of the AGM.

Dr. Feng has confirmed that he has no disagreement with the Board of Directors, and there is no other matter that need to be brought to the attention of the shareholders of the Company ("Shareholders") in relation to his retirement. Dr. Roy Steven Herbst ("Dr. Herbst") and Mr. Qian Zhi ("Mr. Qian") have not stood for re- election as independent non-executive Directors and will retire from their positions with effect from the date of the AGM. Each of Dr. Herbst and Mr. Qian has confirmed that he has no disagreement with the Board of Directors, and there is no other matter that need to be brought to the attention of the Shareholders in relation to his retirement.

The Board of Directors would like to take this opportunity to express its sincere gratitude to Dr. Feng, Dr. Herbst and Mr. Qian for their contributions to the Company during their tenure of office. The two non-employee representative Supervisors, namely Ms. Kuang Hongyan and Ms. Wang Pingping, were elected to the fourth session of the Board of Supervisors at the AGM. Further details are set out in the Company's poll results announcement dated 21 June 2024 and biographical details of the non-employee representative Supervisors are set out in the Company's circular dated 30 May 2024.

At the Company ' s employee representatives meeting held on 20 June 2024 (the " Employee Representatives Meeting"), the employee representatives resolved to appoint Ms. Huo Yilian ("Ms. Huo") as an employee representative Supervisor of the fourth session of the Board of Supervisors. At the first meeting of the fourth session of the Board of Supervisors held on 21 June 2024 (the "Supervisors Meeting"), Ms. Kuang Hongyan ("Ms. Kuang") was elected as the chairman of the fourth session of the Board of Supervisors with a term of office for three years with effect from the date of the Supervisors Meeting until the conclusion of fourth session of the Board of Supervisors. Ms. Huo Yilan, aged 33, has been a purchasing manager and a deputy purchasing director of the Company successively since April 2021.

She has been a supervisor of Shanghai Junshi Xihai Biotechnology Co., Ltd. since September 2021; the executive director and legal representative of Suzhou Junao Cancer Hospital Co., Ltd. since October 2022; and a supervisor of Wuxi Junshi Biomedical Technology Co., Ltd. and Wuxi Runmin Pharmaceutical Technology Co., Ltd. since December 2022. Ms. Huo's main experience prior to joining the Group includes: from November 2016 to May 2017, she served as a commercial operation coordinator at NBCUniversal Inc.; from April 2018 to June 2018, she served as a sales specialist in General Electric (China) Co., Ltd.; and from July 2018 to March 2021, she served as a sales specialist in ABB (China) Co., Ltd. Shanghai Office. Ms. Huo obtained her bachelor's degree in science from Pennsylvania State University, the United States in 2014 and her master's degree in science from New York University, the United States in 2016.